Biosimilars: Current regulatory perspective and challenges
Main Authors: | Diwakar Jha, Ram Kumar Mishra, Rishabh Pandey |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Journal of Pharmacy and Bioallied Sciences |
Online Access: | http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2013;volume=5;issue=1;spage=80;epage=81;aulast=Jha |
Similar Items
-
Current regulatory and market environment for biosimilars in Serbia
by: Pejović Gordana, et al.
Published: (2014-03-01) -
Perspective, perceptions, and promulgation of biosimilars: A questionnaire-based study to assess and understand the current challenges of biosimilars to the potential and intended users
by: Krishan Kumar Bhardwaj, et al.
Published: (2020-01-01) -
Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities
by: Hasumati Rahalkar, et al.
Published: (2021-09-01) -
Regulatory considerations for biosimilars
by: Ranjani Nellore
Published: (2010-01-01) -
The biosimilars journey: current status and ongoing challenges
by: Igor Age Kos, et al.
Published: (2018-10-01)